A possible trend towards a beneficial effect of RAAS inhibitors including aldosterone antagonists (spironolactone and eplerenone) will need to be explored as more data becomes available.
← all excerpts
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.
1
—
—